Origin and functional role of antisense transcription in endogenous and exogenous retroviruses.


Journal

Retrovirology
ISSN: 1742-4690
Titre abrégé: Retrovirology
Pays: England
ID NLM: 101216893

Informations de publication

Date de publication:
16 05 2023
Historique:
received: 31 01 2023
accepted: 30 04 2023
medline: 18 5 2023
pubmed: 17 5 2023
entrez: 16 5 2023
Statut: epublish

Résumé

Most proteins expressed by endogenous and exogenous retroviruses are encoded in the sense (positive) strand of the genome and are under the control of regulatory elements within the 5' long terminal repeat (LTR). A number of retroviral genomes also encode genes in the antisense (negative) strand and their expression is under the control of negative sense promoters within the 3' LTR. In the case of the Human T-cell Lymphotropic Virus 1 (HTLV-1), the antisense protein HBZ has been shown to play a critical role in the virus lifecycle and in the pathogenic process, while the function of the Human Immunodeficiency Virus 1 (HIV-1) antisense protein ASP remains unknown. However, the expression of 3' LTR-driven antisense transcripts is not always demonstrably associated with the presence of an antisense open reading frame encoding a viral protein. Moreover, even in the case of retroviruses that do express an antisense protein, such as HTLV-1 and the pandemic strains of HIV-1, the 3' LTR-driven antisense transcript shows both protein-coding and noncoding activities. Indeed, the ability to express antisense transcripts appears to be phylogenetically more widespread among endogenous and exogenous retroviruses than the presence of a functional antisense open reading frame within these transcripts. This suggests that retroviral antisense transcripts may have originated as noncoding molecules with regulatory activity that in some cases later acquired protein-coding function. Here, we will review examples of endogenous and exogenous retroviral antisense transcripts, and the ways through which they benefit viral persistence in the host.

Identifiants

pubmed: 37194028
doi: 10.1186/s12977-023-00622-x
pii: 10.1186/s12977-023-00622-x
pmc: PMC10186651
doi:

Substances chimiques

Viral Proteins 0

Types de publication

Journal Article Review Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

6

Informations de copyright

© 2023. The Author(s).

Références

Mol Syst Biol. 2012;8:620
pubmed: 23089683
PLoS Pathog. 2014 Apr 03;10(4):e1004040
pubmed: 24699669
J Cell Biol. 2009 Jul 27;186(2):255-68
pubmed: 19635843
APMIS. 2016 Jan-Feb;124(1-2):127-39
pubmed: 26818267
Front Microbiol. 2023 Mar 20;14:1152206
pubmed: 37020719
Retrovirology. 2016 May 03;13(1):33
pubmed: 27141823
Plasmid. 2014 Jul;74:45-51
pubmed: 24971710
J Virol. 1999 Jan;73(1):81-91
pubmed: 9847310
Trends Biochem Sci. 2014 Nov;39(11):556-69
pubmed: 25440716
Nat Med. 2008 Jul;14(7):723-30
pubmed: 18587408
J Virol. 2014 Nov;88(22):13482-94
pubmed: 25210182
Mol Ther. 2014 Jun;22(6):1164-1175
pubmed: 24576854
J Virol. 2011 Dec;85(23):12673-85
pubmed: 21917984
Retrovirology. 2011 Mar 17;8:19
pubmed: 21414204
J Virol. 2019 Oct 15;93(21):
pubmed: 31434734
Adv Virus Res. 2013;85:1-24
pubmed: 23439022
Trends Biochem Sci. 2014 Oct;39(10):496-503
pubmed: 25240485
Cell Cycle. 2010 Apr 1;9(7):1295-1307
pubmed: 20305376
Proc Natl Acad Sci U S A. 2006 May 2;103(18):7054-8
pubmed: 16636284
J Cell Biochem. 2010 Sep 1;111(1):187-94
pubmed: 20506502
PLoS Pathog. 2011 Feb 10;7(2):e1001274
pubmed: 21347344
Noncoding RNA. 2023 Jan 10;9(1):
pubmed: 36649034
Genes Dev. 1995 Jan 1;9(1):72-83
pubmed: 7828853
PLoS Biol. 2007 Jan;5(1):e9
pubmed: 17194214
Cancer Res. 2014 Jan 1;74(1):188-200
pubmed: 24177179
J Virol. 2016 Jan 27;90(7):3760-72
pubmed: 26819304
Cell Rep. 2018 Jun 26;23(13):3710-3720.e8
pubmed: 29949756
APMIS. 2016 Jan-Feb;124(1-2):44-51
pubmed: 26818261
AIDS Res Hum Retroviruses. 1990 Apr;6(4):425-6
pubmed: 2340203
Proc Natl Acad Sci U S A. 2016 Oct 11;113(41):11537-11542
pubmed: 27681623
Oncogene. 2013 Sep 5;32(36):4222-30
pubmed: 23045287
Retrovirology. 2007 Dec 13;4:92
pubmed: 18078517
J Virol. 2008 Oct;82(19):9359-68
pubmed: 18653454
Cell. 2015 Feb 12;160(4):595-606
pubmed: 25640239
Mol Syst Biol. 2011 Feb 15;7:468
pubmed: 21326235
Oncogene. 2014 May 1;33(18):2317-28
pubmed: 23708656
Mol Syst Biol. 2008;4:221
pubmed: 18854820
Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2108-12
pubmed: 1848693
Front Oncol. 2013 Jul 09;3:180
pubmed: 23847768
PLoS Biol. 2007 Sep;5(9):e229
pubmed: 17713988
RNA Biol. 2018;15(8):1025-1031
pubmed: 30146915
Retrovirology. 2009 Feb 02;6:9
pubmed: 19187529
Nucleic Acids Res. 1999 Jan 15;27(2):446-54
pubmed: 9862964
J Virol. 2011 Jul;85(13):6205-11
pubmed: 21507965
Proc Natl Acad Sci U S A. 2021 Apr 27;118(17):
pubmed: 33875584
Front Microbiol. 2017 Nov 20;8:2292
pubmed: 29209299
Cell. 2011 Nov 11;147(4):789-802
pubmed: 22056041
Annu Rev Virol. 2017 Sep 29;4(1):261-285
pubmed: 28715973
Front Microbiol. 2022 Dec 23;13:1042761
pubmed: 36620051
Retrovirology. 2006 Mar 02;3:15
pubmed: 16512901
Essays Biochem. 2013;54:91-101
pubmed: 23829529
J Virol. 2012 Sep;86(17):9070-8
pubmed: 22696638
Dev Biol. 2004 May 1;269(1):276-85
pubmed: 15081373
Blood. 2009 Mar 19;113(12):2755-64
pubmed: 19064727
J Gen Virol. 2021 Dec;102(12):
pubmed: 34939563
J Virol. 1999 Nov;73(11):9496-507
pubmed: 10516058
Elife. 2014 Sep 16;3:e03523
pubmed: 25233276
Genes Dev. 2017 Jan 1;31(1):1-2
pubmed: 28130343
PLoS Biol. 2017 Oct 18;15(10):e2000841
pubmed: 29045398
Retrovirology. 2016 Jan 22;13:7
pubmed: 26800882
Nucleic Acids Res. 2011 Jan;39(2):513-25
pubmed: 20855289
FEBS Lett. 2004 Mar 26;562(1-3):165-70
pubmed: 15044019
Viruses. 2011 May;3(5):456-68
pubmed: 21994742
Cancer Res. 2015 Oct 1;75(19):4143-52
pubmed: 26383166
Biophys J. 2017 Jun 6;112(11):2428-2438
pubmed: 28591615
J Virol. 2006 Mar;80(5):2495-505
pubmed: 16474156
EMBO Rep. 2005 Oct;6(10):956-60
pubmed: 16113646
Mol Cells. 2016 May 31;39(5):367-74
pubmed: 27137091
Retrovirology. 2007 Oct 02;4:71
pubmed: 17910760
Gene. 2006 Feb 1;366(2):335-42
pubmed: 16288839
Mol Syst Biol. 2007;3:138
pubmed: 17893699
J Virol. 2008 Oct;82(19):9329-36
pubmed: 18632860
Nat Cell Biol. 2008 Sep;10(9):1098-105
pubmed: 19160491
Retrovirology. 2015 Feb 27;12:23
pubmed: 25809782
J Virol. 2017 Dec 14;92(1):
pubmed: 29046454
Annu Rev Genomics Hum Genet. 2006;7:149-73
pubmed: 16722807
Retrovirology. 2011 Sep 19;8:74
pubmed: 21929758
Annu Rev Virol. 2019 Sep 29;6(1):365-385
pubmed: 31283437
Viruses. 2022 Jan 14;14(1):
pubmed: 35062351
Science. 2016 Jan 15;351(6270):271-5
pubmed: 26816378
J Virol. 2013 May;87(9):5089-105
pubmed: 23427159
Cytogenet Genome Res. 2005;110(1-4):448-56
pubmed: 16093697
Genes Dev. 1995 Dec 1;9(23):3008-25
pubmed: 7498796
EMBO Rep. 2006 Dec;7(12):1216-22
pubmed: 17139297
J Virol. 2002 Dec;76(24):12813-22
pubmed: 12438606
Virology. 2002 Jan 20;292(2):177-84
pubmed: 11878921
Virology. 1995 Jan 10;206(1):196-202
pubmed: 7831774
Retrovirology. 2015 Feb 02;12:8
pubmed: 25640971
J Virol. 2001 Dec;75(23):11735-46
pubmed: 11689654
Gene. 2001 Apr 18;267(2):157-64
pubmed: 11313142
Cancer Res. 2014 Nov 1;74(21):6082-93
pubmed: 25205102
Blood. 2009 Sep 17;114(12):2427-38
pubmed: 19602711
Cell. 2019 Jun 27;178(1):242-260.e29
pubmed: 31155234
Nucleic Acids Res. 1990 Mar 11;18(5):1261-70
pubmed: 1690875
Retrovirology. 2006 Nov 08;3:80
pubmed: 17090330
Biochem Biophys Res Commun. 1989 Sep 15;163(2):1006-13
pubmed: 2476979
Virology. 1995 Feb 20;207(1):276-81
pubmed: 7755727
J Virol. 2010 Apr;84(8):3780-8
pubmed: 20130045
J Virol. 1996 Mar;70(3):1612-7
pubmed: 8627681
PLoS Pathog. 2020 May 14;16(5):e1008502
pubmed: 32407379
Nat Rev Genet. 2013 Dec;14(12):880-93
pubmed: 24217315
PLoS Pathog. 2013 Sep;9(9):e1003630
pubmed: 24068936
Front Immunol. 2018 Sep 10;9:2039
pubmed: 30250470
Science. 1988 Mar 18;239(4846):1420-2
pubmed: 3347840
Clin Cancer Res. 2002 Jun;8(6):1800-7
pubmed: 12060620
J Virol. 2016 Jan 20;90(7):3600-10
pubmed: 26792732
J Virol. 2012 Jan;86(1):262-76
pubmed: 22031938
Nature. 2001 Feb 15;409(6822):860-921
pubmed: 11237011
FEBS Lett. 2000 Apr 28;472(2-3):191-5
pubmed: 10788609
Retrovirology. 2016 Mar 15;13:16
pubmed: 26979059
Virol Sin. 2015 Jun;30(3):224-7
pubmed: 25912963
Viruses. 2021 Apr 29;13(5):
pubmed: 33946840
Virology. 2017 Jun;506:34-44
pubmed: 28340355
Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):720-5
pubmed: 16407133
J Virol. 1996 Oct;70(10):6665-72
pubmed: 8794302
Retrovirology. 2013 Oct 24;10:118
pubmed: 24156738
PLoS Pathog. 2011 Apr;7(4):e1002025
pubmed: 21552325
Trends Biochem Sci. 2014 Dec;39(12):612-8
pubmed: 25456048
Retrovirology. 2010 Jul 23;7:61
pubmed: 20653953
RNA. 2022 May;28(5):697-710
pubmed: 35168996
BMC Genomics. 2018 May 29;19(1):414
pubmed: 29843593
PLoS Pathog. 2021 Feb 8;17(2):e1009305
pubmed: 33556144
Oncogene. 2005 Feb 3;24(6):1001-10
pubmed: 15592508
Biophys J. 2008 Oct;95(7):3232-8
pubmed: 18599624
Retrovirology. 2014 May 19;11:36
pubmed: 24886479
Arch Virol. 2004 Dec;149(12):2277-94
pubmed: 15338321
J Biol Chem. 2003 Oct 31;278(44):43620-7
pubmed: 12937177
J Biol Chem. 2004 Apr 9;279(15):14871-8
pubmed: 14744852
PLoS Pathog. 2015 Aug 21;11(8):e1005120
pubmed: 26296091
J Virol. 2007 Feb;81(4):1543-53
pubmed: 17151132
Retrovirology. 2012 May 08;9:38
pubmed: 22569184
Vaccines (Basel). 2021 May 17;9(5):
pubmed: 34067514
J Virol. 1994 Feb;68(2):979-87
pubmed: 8289399
Nucleic Acids Res. 1981 Mar 25;9(6):1499-518
pubmed: 7015290
Retrovirology. 2009 Oct 27;6:97
pubmed: 19860877
RNA. 2000 Feb;6(2):170-7
pubmed: 10688356
J Virol. 2019 Jan 4;93(2):
pubmed: 30404795
EMBO J. 1997 Sep 15;16(18):5752-63
pubmed: 9312033
Semin Cell Dev Biol. 2015 Dec;47-48:40-51
pubmed: 26498036

Auteurs

Fabio Romerio (F)

Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. fromeri2@jhmi.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH